Literature DB >> 7509865

Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

H A Jinnah1, B E Wojcik, M Hunt, N Narang, K Y Lee, M Goldstein, J K Wamsley, P J Langlais, T Friedmann.   

Abstract

We have examined several aspects of neurotransmitter function in the brains of mice carrying a deletion mutation in the gene encoding the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). During the first 6 weeks of postnatal development, dopamine levels in whole-brain extracts from the mutant mice (HPRT-) failed to increase at rates comparable to normal animals, resulting in 40% lower dopamine levels throughout adulthood. Regional analysis in adult animals showed the caudoputamen to be the most severely affected region, with dopamine deficits of 48-64%. Dopamine levels in other regions were normal or less severely affected. The decrease in dopamine was accompanied by a decrease in tyrosine hydroxylase (TH) activity, the rate-limiting step in dopamine synthesis. Kinetic analysis of TH extracted from the caudoputamen of normal and HPRT- mice demonstrated a 45% decrease in Vmax with an increased affinity for the tetrahydropterin cofactor in the mutants. Labeling of midbrain dopamine neurons using TH immunohistochemistry revealed no obvious deficits in the number of midbrain dopamine neurons, but quantitative autoradiographic studies revealed significant reductions in the binding of 3H-N-[1-(2-benzo(beta)thiophenyl)cyclohexyl]piperidine (3H-BTCP) to dopamine uptake sites in the forebrain of the mutants. In contrast to these abnormalities of the dopamine systems in the mutant mice, other neurotransmitter systems appeared relatively unaffected. Norepinephrine, 5-HT, tryptophan hydroxylase, and glutamic acid decarboxylase were present at normal levels in the brains of the mutants. ChAT activity was slightly lower than normal in the caudoputamen of the mutant animals, but was normal in all other brain regions examined. These results indicate that HPRT deficiency is associated with a relatively specific deficit in basal ganglia dopamine systems that emerges during the first 2 months of postnatal development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509865      PMCID: PMC6577527     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.

Authors:  Marta G García; Juan G Puig; Rosa J Torres
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

Review 2.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

Review 3.  Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition.

Authors:  R D Todd; J S Perlmutter
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

4.  Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Authors:  Maria G Zizzo; Monica Frinchi; Domenico Nuzzo; Hyder A Jinnah; Giuseppa Mudò; Daniele F Condorelli; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio; Flavia Mulè; Natale Belluardo; Rosa Serio
Journal:  Auton Neurosci       Date:  2017-12-20       Impact factor: 3.145

5.  Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium.

Authors:  T D Southgate; D Bain; L D Fairbanks; A E Morelli; A T Larregina; H A Simmonds; M G Castro; P R Löwenstein
Journal:  Metab Brain Dis       Date:  1999-12       Impact factor: 3.584

6.  Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice.

Authors:  S Brosh; P Boer; O Sperling; E Zoref-Shani
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

7.  Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Authors:  Eric B Dammer; Martin Göttle; Duc M Duong; John Hanfelt; Nicholas T Seyfried; H A Jinnah
Journal:  Mol Genet Metab       Date:  2015-03-05       Impact factor: 4.797

8.  Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Christine Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2019-01-30       Impact factor: 5.996

9.  Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.

Authors:  D F Wong; J C Harris; S Naidu; F Yokoi; S Marenco; R F Dannals; H T Ravert; M Yaster; A Evans; O Rousset; R N Bryan; A Gjedde; M J Kuhar; G R Breese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 10.  Attenuated variants of Lesch-Nyhan disease.

Authors:  H A Jinnah; Irene Ceballos-Picot; Rosa J Torres; Jasper E Visser; David J Schretlen; Alfonso Verdu; Laura E Laróvere; Chung-Jen Chen; Antonello Cossu; Chien-Hui Wu; Radhika Sampat; Shun-Jen Chang; Raquel Dodelson de Kremer; William Nyhan; James C Harris; Stephen G Reich; Juan G Puig
Journal:  Brain       Date:  2010-02-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.